Unknown

Dataset Information

0

Localized Delivery of shRNA against PHD2 Protects the Heart from Acute Myocardial Infarction through Ultrasound-Targeted Cationic Microbubble Destruction.


ABSTRACT: Hypoxia-inducible factor 1? (HIF-1?) plays a critical protective role in ischemic heart disease. Under normoxic conditions, HIF-1? was degraded by oxygen-dependent prolyl hydroxylase-2 (PHD2). Gene therapy has become a promising strategy to inhibit the degradation of HIF-1? and to improve cardiac function after ischemic injury. However, conventional gene delivery systems are difficult to achieve a targeted and localized gene delivery into the ischemic myocardia. Here, we report the localized myocardial delivery of shRNA against PHD2 through ultrasound-targeted microbubble destruction (UTMD) for protection the heart from acute myocardial infarction. In this study, a novel cationic microbubble was fabricated by using of the thin-film hydration and sonication method. The resulting microbubbles had a 28.2 ± 2.21 mV surface zeta potential and could greatly improve DNA binding performance, achieving 17.81 ± 1.46 ?g of DNA loading capacity per 5 × 108 microbubbles. Combined with these cationic microbubbles, UTMD-mediated gene delivery was evaluated and the gene transfection efficiency was optimized in the H9C2 cardiac cells. Knockdown of PHD2 gene was successfully realized by UTMD-mediated shPHD2 transfection, resulting in HIF-1?-dependent protective effects on H9C2 cells through increasing the expression of HIF-1?, VEGF and bFGF. We further employed UTMD-mediated shPHD2 transfection into the localized ischemic myocardia in a rat ischemia model, demonstrating significantly reduced infarct size and greatly improved the heart function. The silencing of PHD2 and the up-regulation of its downstream genes in the treated myocardia were confirmed. Histological analysis further revealed numbers of HIF-1?- and VEGF-, and CD31-positive cells/mm2 in the shPHD2-treated group were significantly greater than those in the sham or control vector groups (P < 0.05). In conclusion, our study provides a promising strategy to realize ultrasound-mediated localized myocardial shRNA delivery to protect the heart from acute myocardial infarction via cationic microbubbles.

SUBMITTER: Zhang L 

PROVIDER: S-EPMC5196885 | biostudies-other | 2017

REPOSITORIES: biostudies-other

altmetric image

Publications

Localized Delivery of shRNA against PHD2 Protects the Heart from Acute Myocardial Infarction through Ultrasound-Targeted Cationic Microbubble Destruction.

Zhang Li L   Sun Zhenxing Z   Ren Pingping P   You Manjie M   Zhang Jing J   Fang Lingyun L   Wang Jing J   Chen Yihan Y   Yan Fei F   Zheng Hairong H   Xie Mingxing M  

Theranostics 20170101 1


Hypoxia-inducible factor 1α (HIF-1α) plays a critical protective role in ischemic heart disease. Under normoxic conditions, HIF-1α was degraded by oxygen-dependent prolyl hydroxylase-2 (PHD2). Gene therapy has become a promising strategy to inhibit the degradation of HIF-1α and to improve cardiac function after ischemic injury. However, conventional gene delivery systems are difficult to achieve a targeted and localized gene delivery into the ischemic myocardia. Here, we report the localized myo  ...[more]

Similar Datasets

| S-EPMC7163444 | biostudies-literature
| S-EPMC4548789 | biostudies-literature
| S-EPMC5826859 | biostudies-literature
| S-EPMC8021517 | biostudies-literature
| S-EPMC5928888 | biostudies-literature
| S-EPMC5033025 | biostudies-literature
| S-EPMC8377464 | biostudies-literature
| S-EPMC5240524 | biostudies-literature
| S-EPMC6540049 | biostudies-literature
| S-EPMC8117937 | biostudies-literature